Conflicting Opinions Flood FDA on Its Proposal for Biosimilar Naming

相似書籍

• FDA Pleases No One With Final Guidance On Naming of Biologicals and Biosimilars
  由: Barlas, Stephen
  出版: (2017)
• FDA Accepts Its First Biosimilar Application: However, the Agency’s Requirements Are Still Unclear
  由: Barlas, Stephen
  出版: (2014)
• FDA Advisory Committee Approval of First Biosimilar Leaves Questions Unanswered: Sandoz’s Filgrastim Faces Naming and Court Hurdles
  由: Barlas, Stephen
  出版: (2015)
• Congress Enters Contentious Debate on Biosimilar Naming: Bill Provision Sides With Brand-Name Companies Over USP
  由: Barlas, Stephen
  出版: (2016)
• FDA Wants Companies to Simplify Drug Packaging, Naming, and Labeling To Reduce Medication Errors
  由: Barlas, Stephen
  出版: (2010)